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Psoriasis is a common chronic and complex autoimmune inflammatory skin disorder. The histological
characteristics of psoriasis are epidermal hyperplasia, mononuclear leukocyte infiltration into the dermis, and
increased angiogenesis. However, the mechanisms involved in the pathogenesis of psoriasis remain unclear.
Extracellular superoxide dismutase (EC-SOD) has antichemotactic activities. Because immune cell infiltration is
seen in psoriatic lesions and psoriasis patients express low levels of EC-SOD, we hypothesized that the lack of EC-
SOD induces more severe IL-23-mediated psoriasis-like skin inflammation. To test this hypothesis, we determined
whether the loss of EC-SOD causes more severe IL-23-induced skin inflammation. Ear skin after IL-23
administration was thicker in EC-SOD knockout (KO) mice compared with wild-type mice. In addition, infiltration
of CD4þ T cells, macrophages, and dendritic cells (DCs) into IL-23 injection sites was more elevated in EC-SOD
KO mice. The expression of proinflammatory cytokines and chemokines was also more elevated in EC-SOD KO
mice, and EC-SOD KO DCs expressed a higher level of MHCII. Finally, EC-SOD transgenic mice showed much
less severe IL-23-induced skin inflammation. Therefore, EC-SOD may inhibit IL-23-induced psoriasis-like
inflammation through the inhibition of immune cell infiltration and immune responses. These results suggest
that EC-SOD could be a possible candidate for management of psoriasis.
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INTRODUCTION
Psoriasis is an immune cell–mediated chronic skin inflammatory
disorder. Although its etiology is largely unknown, it is believed
that psoriasis is an autoimmune inflammatory disease with a
genetic basis (Lowes et al., 2007). Previously, it was thought that
IFN-g-producing Th1 cells were the major factors in the induc-
tion of psoriasis. However, accumulating evidence suggests that
Th17 cells may be a major factor of psoriasis pathogenesis
(Cesare et al., 2009, Tonel et al., 2010, Rizzo et al., 2011).
Naive CD4þ T cells differentiate into Th1, Th2, Th17, or
regulatory T cells in response to specific cytokines released by
antigen-presenting cells (Stockinger and Veldhoen, 2007).
Treatment with IL-12 or IL-4 differentiates naive CD4þ T
cells into Th1 or Th2 cells, respectively. Differentiation of
naive CD4þ T cells into Th17 cells is induced by IL-6 and
transforming growth factor-b (TGF-b) (Bettelli et al., 2006;
Mangan et al., 2006). STAT3 and RORgT transcription factors
are also required for Th17 cell differentiation (Ivanov et al.,
2006; Nurieva et al., 2007). In psoriasis, TGF-b levels are
elevated in plasma and lesions (Flisiak et al., 2002). Thus, the
elevated TGF-b levels may induce Th17 cell differentiation
with IL-6 secreted from activated antigen-presenting cells.
Although IL-6 and TGF-b are important for Th17 cell
differentiation, IL-23 is critical for the maintenance and survival
of Th17 cells. In psoriatic skin, IL-23 is mainly produced by
inflammatory dendritic cells (DCs; Lee et al., 2004; Piskin
et al., 2006; Lillis et al., 2010) and is a critical factor for
psoriasis pathogenesis (Di Cesare et al., 2009). Both IL-6 and
IL-23 activate STAT3 for signal transduction (Chen et al., 2007).
Thus, STAT3 is one of the major targets for the treatment of
Th17-derived diseases including some autoimmune diseases.
Indeed, loss of STAT3 inhibits the development of experimental
autoimmune encephalitis and experimental autoimmune
uveitis (Liu et al., 2008). In addition, constitutively active
STAT3 in keratinocytes induces psoriasiform lesions following
wounding stimuli or topical treatment with 12-O-tetrade-
canoylphorbol-13-acetate, indicating that STAT3 activation in
keratinocytes may also be involved in the development of
psoriasis (Sano et al., 2005; Sano et al., 2008). Therefore,
STAT3 activation is important for psoriasis pathogenesis.
Extracellular superoxide dismutase (EC-SOD), also known as
SOD3, catalyzes the dismutation of superoxide anions and is
present in the extracellular matrix (Marklund, 1982). Thus, EC-
SOD is implicated in reactive oxygen species–mediated tissue
damage. EC-SOD is composed of three functional regions: the
N-terminal region is involved in tetramerization (Stenlund
et al., 1997); central region is necessary for the coordination
of metals (Hjalmarsson et al., 1987); and the C-terminal region
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is required for binding to the ligand, such as heparin sulfate,
typeI collagen, and hyaluronan in extracellular matrix
(Sandstrom et al., 1992; Petersen et al., 2004; Gao et al.,
2008). The C-terminal region gives EC-SOD a distinguishing
property in that it has high affinity for ligands in the extracellu-
lar matrix. EC-SOD has antiangiogenic, anti-inflammatory,
antichemotactic and antitumoric activity. Recently, we
determined that EC-SOD inhibited the synthesis of new
blood vessels, epidermal edema, and proinflammatory cell
infiltration into mouse skin when mice were irradiated with
UV. More interestingly, skin biopsies from psoriatic patients
expressed lower levels of EC-SOD compared with those from
healthy donors (Kim et al., 2011). This observation led us to
investigate the role of EC-SOD in psoriasis pathogenesis.
Intradermal injection of murine IL-23 (mIL-23) into murine
skin induces psoriasis-like inflammation (Zheng et al., 2007;
Hedrick et al., 2009). Therefore, studies of IL-23-induced
skin inflammation in mice are useful for understanding the
mechanisms involved in psoriatic inflammation. In this study,
we investigated the role of EC-SOD in psoriasis pathogenesis by
comparing IL-23-mediated skin inflammation and by characte-
rizing immune cells in wild-type (WT) and EC-SOD knockout
(KO) mice. Our results suggest that EC-SOD inhibits IL-23-
induced skin inflammation by reducing infiltration of proinfla-
mmatory cells in skin and by inhibiting immune cell activation.
RESULTS
Deficiency of EC-SOD induces more severe IL-23-mediated
psoriasiform skin inflammation
Intradermal injection of mIL-23 into mouse ears induces
psoriasis-like skin inflammation (Hedrick et al., 2009). To
investigate the role of EC-SOD in psoriasis pathogenesis, we
used WT and EC-SOD KO mice. Mice were intradermally
injected with mIL-23 every other day for 15 days and were
then killed on day 15 (Figure 1a). Hematoxylin and eosin
staining of sections from WT ears injected with mIL-23
showed increased epidermal thickness and infiltration of
mononuclear cells into the dermis on day 15 (Figure 1b).
However, mIL-23-injected EC-SOD KO ears showed more
increases in epidermal thickness and mononuclear cell infil-
tration compared with those of WT mice (Figure 1b). Ear
thickness in mIL-23-injected WT mice increased by 70mm.
On the other hand, ear thickness in mIL-23-injected EC-SOD
KO mice increased by 130mm. Thus, the loss of EC-SOD
induced more severe IL-23-mediated skin inflammation,
implying that EC-SOD has an inhibitory effect on IL-23-
mediated skin inflammation.
CD4þ T cells, CD11bþ cells, and CD11cþ cells were more
infiltrated in IL-23-injected EC-SOD KO mouse ear
To determine which cells and how many cells are recruited
into WT and EC-SOD KO ear following intradermal injections
of mIL-23, we prepared single-cell suspensions from PBS- or
mIL-23-injected WT and EC-SOD mouse ears on day 15 and
analyzed the cells by flow cytometry. CD4þ T cells,
CD11bþ cells, and CD11cþ cells were recruited into mIL-
23-injected EC-SOD KO mouse ears at a 3-fold greater rate
than mIL-23-injected WT mouse ears (Figure 2a). We also
measured the expression levels of IFN-g and IL-17 in PBS- or
mIL-23-injected mouse ears. As expected, the expression
levels of IL-17 were higher in mIL-23-injected EC-SOD KO
mouse ears compared with mIL-23-injected WT mouse ears.
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Figure 1. Extracellular superoxide dismutase (EC-SOD)–deficient mice induce more severe IL-23-mediated psoriasiform skin inflammation. (a) Groups of wild-
type (WT) and EC-SOD knockout (KO) mice were injected intradermally with IL-23 every other day for 15 days. (b) Histology of ear skin. Sections of ears recovered
from WT or EC-SOD KO mice were stained with hematoxylin and eosin. EC-SOD KO mice showed a higher number of infiltrated cells compared with WT mice.
(c) IL-23-injected EC-SOD KO mouse ear skin showed more increased ear thickness compared with WT mouse ear skin. Data are from three independent
experiments with four mice per group. *Po0.05. PBS, phosphate-buffered saline. Bar¼ 50mm.
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However, IFN-g expression levels were lower in mIL-23-
injected EC-SOD KO mouse ears (Figure 2b). These results
imply that a loss of EC-SOD induces infiltration of proin-
flammatory mononuclear cells into mIL-23-injected sites and
that IL-17 is a key cytokine involved in the severe IL-23-
induced skin inflammation seen in EC-SOD KO skin. Expres-
sion levels of IL-1b, IL-6, IL-22, and tumor necrosis factor-a
(TNF-a), which are involved in pathogenesis of psoriasis, were
also increased in mIL-23-injected EC-SOD KO mouse ears
compared with IL-23-injected WT mouse ears (Figure 2b).
Chemokine gene expression was elevated in mIL-23-injected
EC-SOD KO mouse skin
The recruitment of proinflammatory mononuclear cells is
controlled by chemokine gene expression at the inflammation
site. Therefore, chemokine gene expression levels were
determined in mIL-23-injected WT and EC-SOD KO mouse
ears. Expression levels of CCL17, CCL20, and CXCL1, which
are highly expressed in psoriasis (Gillitzer et al., 1996;
Rottman et al., 2001; Hedrick et al., 2009), were higher in
mIL-23-injected EC-SOD KO mouse ears than in mIL-23-
injected WT mouse ears (Figure 3a). Thus, increased infiltra-
tion of mononuclear cells resulted from elevated chemokine
expression in EC-SOD KO mouse ears. To confirm these
results, we performed an in vitro experiment using recombi-
nant EC-SOD (rEC-SOD) protein. Stimulation of the keratino-
cyte cell line HaCaT with TNF-a/IFN-g induces chemokine
gene expressions. In addition, HaCaT cells express the IL-22
receptor. Therefore, HaCaT cells were cultured with TNF-a/
IFN-g or IL-22 with or without rEC-SOD treatment to deter-
mine whether rEC-SOD could inhibit cytokine-induced che-
mokine gene expression in keratinocytes. Consistent with the
in vivo experiment, treatment with rEC-SOD reduced TNF-a/
IFN-g- or IL-22-induced chemokine gene expression in the
keratinocyte cell line (Figure 3b and c).
A lack of EC-SOD affects the expression of activation markers
and secretion of cytokines in DCs
Psoriasis is a CD4þ T cell–mediated skin inflammatory
disease. Therefore, CD4þ T-cell activation is necessary for
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Figure 2. More immune cells were infiltrated in IL-23-injected extracellular superoxide dismutase (EC-SOD) knockout (KO) mouse ear. (a) More CD4þ T cell,
CD11bþ , macrophage marker, cells and CD11cþ , dendritic cell marker, cells are infiltrated in IL-23-injected EC-SOD KO mouse ear skin. (b) Expression level of
IFN-g is lower but the expression level of IL-17 is higher in IL-23-injected EC-SOD KO mouse ear compared with IL-23-injected wild-type (WT) mouse ear. Gapdh
messenger RNA was used as an internal control. A representative example of four independent experiments is shown. *Po0.05 and **Po0.005. Differences with
*Po0.05 and **Po0.005 were considered statistically significant. a.u., arbitrary unit; PBS, phosphate-buffered saline; TNF-a, tumor necrosis factor-a.
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psoriasis pathogenesis. Because DC maturation is required for
CD4þ T-cell activation, we determined the effect of EC-SOD
on DC maturation. Immature DCs were generated from WT or
EC-SOD KO bone marrow cells. For maturation, immature
DCs were treated with TNF-a (10 ng ml 1) overnight because
DCs can be activated by TNF-a, and TNF-a is one of the
cytokines involved in psoriasis pathogenesis. Consistent with
the result from lipopolysaccharide-stimulated DCs (data not
shown), TNF-a-stimulated EC-SOD KO DCs expressed
increased levels of maturation markers compared with TNF-
a-stimulated WT DCs. In particular, expression levels of
CD40, CD86, and MHCII were highly increased (Figure 4a).
On the other hand, treatment with rEC-SOD inhibited the
elevated levels of CD40, CD86, and MHCII expression
(Figure 4a bottom panel). These results suggest that a lack of
EC-SOD in DCs could result in more active CD4þ T cells,
implying that the more severe IL-23-mediated skin inflamma-
tion in EC-SOD KO mice could, at least in part, be a result of
more activated DCs.
Secretion of cytokines by DCs also influences CD4þ T-cell
differentiation. Thus, we investigated the effect of EC-SOD on
DC cytokine expression. EC-SOD KO DCs expressed a lower
level of IFN-g than did WT DCs, whereas IL-6 expression was
not affected (Figure 4b and c). ELISA data were consistent with
real-time PCR results. Treatment of WT DCs with rEC-SOD
also increased IFN-g expression and production, but did not
affect IL-6 gene expression and protein production (Figure 4d
and e).
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Figure 3. Chemokine gene expression is higher in IL-23-injected extracellular superoxide dismutase (EC-SOD) knockout (KO) mouse skin. (a) Expression levels of
CCL17, CCL20, and CXCL1 were higher in IL-23-injected mouse ear compared with IL-23-injected wild-type (WT) mouse ear. Treatment with recombinant
extracellular superoxide dismutase (rEC-SOD) inhibited (b) tumor necrosis factor-a (TNF-a)/IFN-g-induced and (c) IL-22-induced chemokine expression in HaCaT
cell line. Gapdh messenger RNA was used as an internal control. A representative example of three independent experiments is shown. *Po0.05 and **Po0.005.
Differences with *Po0.05 and **Po0.005 were considered statistically significant. a.u., arbitrary unit; PBS, phosphate-buffered saline.
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EC-SOD-deficient naive CD4þ T cells are more differentiated
into Th17 cells
To determine the effect of EC-SOD on CD4þ T-cell differ-
entiation, purified naive CD4þ T cells were cultured
under Th1 or Th17 differentiation conditions for 4 days, and
then real-time PCR and ELISA were performed. EC-SOD-
deficient naive CD4þ T cells differentiated less into Th1 cells
than did WT naive CD4þ T cells (Figure 5a and b). On the
other hand, EC-SOD-deficient naive CD4þ T cells differen-
tiated more into Th17 cells than did WT naive CD4þ T cells.
Therefore, EC-SOD positively regulates Th1 cell differentia-
tion, but downregulates Th17 cell differentiation. Carboxy-
fluorescein succinimidyl ester (CFSE) dilution assay was also
performed to determine the effect of EC-SOD on CD4þ T-cell
proliferation. Figure 5c shows that EC-SOD-deficient CD4þ T
cells proliferated faster than WT CD4þ T cells, implying that
EC-SOD may inhibit CD4þ T-cell proliferation. Figure 5d
showed that the most abundant population was two times
divided and three times divided cells in WT CD4þ T cells
and EC-SOD KO CD4þ T cells, respectively. Indeed, treat-
ment of rEC-SOD inhibited CD4þ T-cell proliferation
(Figure 5e). The level of IL-2 was also determined, because
it is secreted from activated CD4þ T cells. When antigen-
presenting cells from Balb/c mice and CD4þ cells from
DO11.10 were cocultured with OVA323–339 peptide, treat-
ment with rEC-SOD decreased the level of IL-2 (Figure 5f).
This result indicates that rEC-SOD inhibits CD4þ T-cell
activation and is consistent with the result of the CD4þ T-cell
proliferation assay (Figure 5c).
EC-SOD transgenic mice were partially resistant to IL-23-
induced psoriasis-like skin inflammation
To confirm the inhibitory effect of EC-SOD on IL-23-induced
psoriasis-like skin inflammation, we induced IL-23-induced
skin inflammation with EC-SOD transgenic (TG) mice and
wild-type mice. Figure 6a showed that a large number of
proinflammatory cells were infiltrated into wild-type mouse
skin, whereas much less cells were infiltrated into EC-SOD
TG mouse skin. Thickness of the epidermis and dermis was
also narrower in EC-SOD TG mouse skin (Figure 6a). Further-
more, expression levels of proinflammatory cytokines,
IL-1b, IL-6, IL-17, and TNF-a, and chemokines, CCL17,
CCL20, and CXCL1, were lower in mIL-23-injected EC-SOD
TG mouse skin compared with mIL-23-injected wild-type
mouse skin (Figure 6b and c). These results suggested
that EC-SOD might be a therapeutic candidate to control
psoriasis.
DISCUSSION
Psoriasis is an immune-mediated chronic skin disease that
affects 2–3% of the population worldwide (Schon and
Boehncke, 2005). Despite the importance of this disease,
current therapies are not effective in some patients.
Furthermore, the exact causes of psoriasis still remained to
be elucidated, although it is thought that genetic and
environmental factors are involved. Therefore, understanding
the detailed mechanisms involved in psoriasis pathogenesis is
necessary for the development of more effective treatments.
In the 1970s, it was believed that psoriasis resulted from
excessive proliferation and altered differentiation of keratino-
cytes. However, it was later proposed in the 1980s that
psoriasis was a T cell–mediated disease. Recently, accumulat-
ing evidence suggests that Th17 cells are important in psoriasis
pathogenesis (Blauvelt, 2007). Naive CD4þ T cells
differentiate into Th17 cells through CD4þ T-cell activation
and stimulation by IL-6 and TGF-b1. It is also proposed that
IL-23 is necessary for the survival and proliferation of Th17
cells. Because IL-6 and IL-23 activate the STAT3 signaling
pathway, inhibition of STAT3 activation may be a possible
way to inhibit Th17 cell differentiation. Our results showed
that EC-SOD did not affect IL-6 expression in DCs (Figures 5a
and b). However, EC-SOD inhibited CD4þ T-cell proliferation
(Figures 6c and d) and expression of maturation markers that
are required for CD4þ T-cell activation by DCs (Figure 4).
Thus, more Th17 cells differentiated from EC-SOD-deficient
CD4þ T cells than from WT CD4þ T cells possibly because of
enhanced expression of maturation marker of DCs and
activation of CD4þ T cells.
The infiltration of proinflammatory cells such as T cells,
DCs, and macrophages to the dermis and epidermis of
psoriatic skin lesions is another feature of psoriasis (Schon
and Boehncke, 2005). IL-23-mediated skin inflammation also
involves the infiltration of mononuclear cells into the
epidermis and dermis, resulting in thickened epidermis and
dermis (Hedrick et al., 2009). Therefore, recruitment of
immune cells to the skin is an important step of psoriasis
pathogenesis. For recruitment of immune cells into psoriatic
lesions, chemokine expression in the lesion is necessary.
Indeed, CCL17, CCL20, CCL27, and CXCL1 are highly
expressed in psoriatic lesions (Nickoloff et al., 2007).
Consistently, our results showed that the expression levels of
CCL17, CCL20, CCL27, and CXCL1 were elevated in
mIL-23-injected WT mouse ears. However, the chemokine
expression levels were higher in mIL-23-injected EC-SOD KO
mouse ears than in mIL-23-injected WT mouse ears,
Figure 4. Effects of extracellular superoxide dismutase (EC-SOD) on dendritic cells. Dendritic cells were generated from wild-type (WT) and EC-SOD knockout
(KO) bone marrow cells as described in Materials and Methods. (a) After activation with tumor necrosis factor-a (TNF-a; 10 ng ml 1) stimulation, various
maturation markers were stained, followed by flow cytometry. EC-SOD KO dendritic cells expressed more CD40, CD86, and MHCII, and treatment of EC-SOD
KO dendritic cells with recombinant extracellular superoxide dismutase (rEC-SOD) inhibited the increased expression of maturation markers. A representative
example of three independent experiments is shown. (b) RNA level and (c) secretion of IFN-g and IL-6 from matured WT or EC-SOD KO dendritic cells were
measured. EC-SOD KO dendritic cells produce less amount of IFN-g at the RNA and protein levels. The level of IL-6 was not different between WT and EC-SOD
KO dendritic cells. (d) RNA level and (e) secretion of IFN-g and IL-6 from rEC-SOD-treated WT dendritic cells were measured. Treatment of WT dendritic cells with
rEC-SOD increased IFN-g at the RNA and protein levels. However, rEC-SOD did not have any effect at the IL-6 level. A representative example of four independent
experiments is shown. *Po0.05.
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indicating that EC-SOD inhibits chemokine expression in
mouse skin (Figure 3). This result is consistent with a previous
report that showed that EC-SOD reduces inflammatory cell
migration (Laurila et al., 2009). In addition, EC-SOD TG
mouse showed decreased infiltration of proinflammatory
cells and hyperplasia compared with WT mouse (Figure 6).
Therefore, the inhibitory effects of EC-SOD on psoriasis
may result from somewhat reduced CD4þ T-cell proliferation
and Th17 cell differentiation and the inhibited recruitment of
proinflammatory cells into skin.
Previously, we demonstrated that EC-SOD expression levels
are lower in psoriatic skin than in normal skin (Kim et al.,
2011). Because EC-SOD is downregulated by TNF-a (Stralin
and Marklund, 2000), and TNF-a is highly expressed in
psoriatic lesions, it is possible that the lower level of
EC-SOD in psoriasis is due to increased TNF-a production.
The TNF-a inhibitors, infliximab and etanercept, are effective
for the treatment of psoriasis (Krueger and Callis, 2004). In
addition, it was reported that infliximab protected EC-SOD
from decreased expression of EC-SOD by TNF-a in vitro
(Adachi et al., 2006). Therefore, further studies will be
necessary to determine whether the effects of TNF-a
inhibitors on psoriasis are due to increased EC-SOD levels.
EC-SOD is associated with the pathogenesis of a variety of
diseases including vascular and lung diseases (Fattman et al.,
2003). In this study, we demonstrated that psoriasis
pathogenesis also involves altered EC-SOD expression.
Consistently, decreased expression of EC-SOD and its
activity are related to rheumatoid arthritis, a Th17 cell–
driven autoimmune disease (Afonso et al., 2007).
Because psoriasis pathogenesis is similar to that of other
Th17 cell–driven autoimmune diseases, including inflamma-
tory bowel disease, rheumatoid arthritis, multiple
sclerosis, and uveitis (Amadi-Obi et al., 2007; Blauvelt,
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Figure 5. Extracellular superoxide dismutase (EC-SOD) affects CD4þ T-cell differentiation and activation. (a, b) ELISA and quantitative real-time PCR data
showed that EC-SOD-deficient naive CD4þ T cells were more differentiated into Th17 cells but less differentiated into Th1 cells. Naive CD4þ T cells were
cultured with anti-CD3, anti-CD28, anti-IL-4 antibodies, and IL-12 (10 ng ml 1) for Th1 differentiation. For Th17 cell differentiation, naive CD4þ T cells were
cultured with anti-CD3, anti-CD28, anti-IFN-g, anti-IL-4 antibodies, transforming growth factor-b (TGF-b; 5 ng ml1), and IL-6 (10 ng ml1). (c) Carboxyfluorescein
succinimidyl ester (CFSE) dilution assay showed that EC-SOD knockout (KO) CD4þ T cells proliferated faster than wild-type (WT) CD4þ T cells. (d) Thrice-divided
cells were most abundant in EC-SOD KO CD4þ T cells, whereas twice-divided cells were most abundant in WT CD4þ T cells. (e) Treatment with recombinant
extracellular superoxide dismutase (rEC-SOD; 200 U ml 1) inhibited the proliferation of WT CD4þ T cells. (f) IL-2 secretion of antigen-specific CD4þ T cells was
also inhibited by treatment with rEC-SOD. g-Irradiated splenocytes as antigen-presenting cells from Balb/c mice and naive CD4þ T cells from DO11.10 mice were
cocultured with or without Ova 323–339 peptide for 3 days. Treatment with rEC-SOD inhibited IL-2 production from Ova-specific CD4
þ T cells. A representative
example of three independent experiments is shown. *Po0.05 and **Po0.005. Differences with *Po0.05 and **Po0.005 were considered statistically
significant. a.u., arbitrary unit.
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2007), it will be interesting to investigate the role of EC-SOD
in other autoimmune diseases, and EC-SOD may be a good
candidate for use in the treatment of other autoimmune
diseases.
MATERIALS AND METHODS
Mice
Mice were housed in an environmentally controlled room with a
12-hour/12-hour light–dark cycle and with free access to laboratory
chow and water. EC-SOD KO mice were previously described
(Carlsson et al., 1995). Mice were back-crossed with the C57BL/6
strain 10 times. EC-SOD TG mice were generated by pronuclear
injection of EC-SOD plasmid containing b-actin promoter and poly-A
sequence. Mice between 8 and 12 weeks of age were used. The
protocol for mouse use was approved by the Catholic Research
Institute of the Medical Science Committee.
Cell line and reagents
The immortalized human keratinocyte cell line HaCaT was pur-
chased from cell line service(Eppelheim, Germany) and was grown as
monolayer cultures in DMEM supplemented with 10% fetal bovine
serum, 1% penicillin, and streptomycin. TRIzol reagent was pur-
chased from Invitrogen (Carlsbad, CA).
Intradermal injection of recombinant mIL-23
PBS (20ml) or recombinant mIL-23 (500ng per 20ml) was injected
intradermally into the ears of WT or EC-SOD KO mice every other day
for 15 days. On day 15, ears were collected and stored at  80 1C until
use for real-time PCR experiment, or they were fixed at 4%
paraformaldehyde for paraffin section. For flow cytometry, the ears
were collected and cell suspensions from the ears were prepared as
previously described (Belkaid et al., 2001). Briefly, ventral and dorsal
dermal sheets of the ears were separated from cartilage and incubated
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WT or EC-SOD TG mice were stained with hematoxylin and eosin. EC-SOD TG mouse ear skin showed less number of infiltrated cells compared with WT
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for 45 minutes at 37 1C in RPMI 1640 containing Liberase. After
incubation, ear sheets were disrupted mechanically. Cells were filte-
red through a 70-mm nylon mesh, collected, and stained with fluore-
scence-conjugated anti-CD3, anti-CD4, anti-CD11b, and anti-CD11c
antibodies (BD Biosciences). A total of 5 105 stained cells were
acquired for flow cytometry, and the number of CD4þ , CD11bþ ,
and CD11Cþ cells were counted using the FlowJo software (Tree Star,
San Carlos, CA).
RNA isolation, complementary DNA synthesis, and quantitative
real-time PCR
Total RNA was isolated from HaCaT cells or mouse skin using TRIzol
reagent (Invitrogen). The first strand of complementary DNA was
synthesized from 1mg of total RNA using a reverse transcription
system (Qiagen, Hilden, Germany). The primer sets for IL-6, IL-17,
TNF-a, CXCL1, CCL17, and CCL20 were purchased as the Quanti-
Tect primer assay (Qiagen). GAPDH messenger RNA was used as an
endogenous control. PCR was performed using Rotor-Gene 6000
(Corbett, Mortlake, NSW, Australia) and a QuantiTect SYBR Green
PCR Kit (Qiagen). The amplification program consisted of 1 cycle at
95 1C for 10 minutes, followed by 35 cycles at 95 1C for 20 seconds,
55 1C for 20 seconds, and 72 1C for 20 seconds.
Generation of CD11cþ DCs
CD11cþ DCs were generated from murine bone marrow as pre-
viously described, with minor modifications (Lee et al., 2011). Briefly,
bone marrow cells were obtained from tibias and femurs of 8- to 10-
week-old C57BL/6 WT or EC-SOD KO mice. Lineage-negative cells
from bone marrow cells were isolated using a lineage-negative cell
isolation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany) accord-
ing to the manufacturer’s protocol. The lineage-negative cells were
grown with DMEM supplemented with 10% fetal bovine serum,
granulocyte–macrophage colony-stimulating factor (10 ng ml 1), and
IL-4 (10 ng ml 1) for 5 days. For activation of DCs, lipopolysacchar-
ide (1mg ml 1) was added and the cells were cultured for 16 hours.
ELISA
CD4þ T cells were purified from the lymph nodes and spleens of
C57BL/6 mice. For the isolation of CD4þ T cells, the lymph node
cells and splenocytes were loaded onto T-cell enrichment columns,
and the elutant was used to purify CD4þ T cells using CD4þ
CD62Lþ T-cell isolation kit as specified by the manufacturer
(Miltenyi Biotec). WT or EC-SOD KO naive CD4þ T cells were
cultured under Th1 or Th17 polarization conditions for 4 days. The
supernatants were collected and stored at  80 1C until use. ELISA for
IFN-g or IL-17 was performed according to the manufacturer’s
protocol (BD Biosciences).
CFSE dilution assay
CFSE dilution assay was performed using the CellTrace CFSE Cell
Proliferation Kit (Molecular Probes, Eugene, OR) according to the
manufacturer’s protocol. Briefly, purified naive CD4þ T cells were
incubated with CFSE at 37 1C for 10 minutes. After quenching
the staining by the addition of ice-cold culture medium, cells
were incubated for 5 minutes on ice, after which they were collected
and washed. Cells were cultured with anti-CD3/CD28 antibodies
(BD Biosciences) for 4 days. Graphical display showing each cell
division obtained from the FlowJo software.
Statistical analysis
Data are presented as means±SEM, and statistical comparisons
between groups were made with the unpaired two-sided t-test. All
experiments were performed at least three times. Differences with
*Po0.05 and **Po0.005 were considered statistically significant.
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